products catalog

ECI2012’s mission is to offer and maintain niche products on the market, which would have been otherwise discontinued by the major pharmaceutical companies.

At ECI2012, we are committed to provide access to these drugs for all Canadian patients across Canada.

Our Values - Respect for patients who are the cornerstone of ECI2012’s success. - Customer-focused; we are committed to meet the needs of all our customers

and business partners. - Integrity: we expect oursleves and others to meet the highest ethical stan-

dards, so as to deliver highest quality products and processes. - The quality of our products and our personnel is a value deeply entrenched in

our daily activities.

ERFA Canada 2012 Inc. (ECI2012) offers a diversified range of products in various thera-peutic classes such as :

•Oncology •Cardiovascular •Antibiotics •Analgesics •Antidepressant •Others

BroncholidatorCHOLEDYL ELIXIR is indicated for the symp -tomatic relief of reversible bronchocons-triction associated with bronchial asthma, chronic obstructive pulmonary emphysema, chronic bronchitis and related bronchospas-tic disorders.

Bronchodilator – ExpectorantCHOLEDYL EXPECTORANT ELIXIR is indicated for the symptom-atic relief of reversible bronchoconstriction associated with bron-chial asthma, chronic obstructive pulmonary emphysema, chronic bronchitis and related bronchospastic disorders, and where expec-toration is required.

CHOLEDYLEXPECTORANTELIXIR®

(Oxtriphylline - Guaifenesin, USP)100 mg Oxtriphylline and 50 mg Guaifenesin / 5 mL

CHOLEDYLELIXIR®

(Oxtriphylline Oral Solution, USP)100 mg/5 mL

CARDIOVASCULAR/RESPIRATORY

Choledyl*

Elixir/Élixir

500 mL

DIN 00476366Pr

OXTRIPHYLLINE ORALSOLUTION U.S.P.SOLUTION ORALED'OXTRIPHYLLINE, USP

306H586C32591

BRONCHODILATOR/BRONCHODILATATEUREach 5 mL (1 teaspoonful) contains100 mg oxtriphylline (equivalent to 64 mg anhydrous theophylline) and alcohol20% v/v.Usual Maintenance Dosage: Patients over 14 years of age: 2 teaspoonfuls 4 times daily. Children 10 to 14 years: 1 to2 teaspoonfuls 4 times daily. Not recommended for children under10 years of age.Prescribing Information available to physicians and pharmacists on request.Une dose de 5 mL (1 c. à thé) contient100 mg d’oxtriphylline (équivalant à64 mg de théophylline anhydre) et 20 % d’alcool v/v.Posologie d’entretien habituelle : patients de plus de 14 ans : 2 c. à thé4 fois par jour; enfants de 10 à 14 ans :1 à 2 c. à thé 4 fois par jour. Non recommandé chez les enfants de moins de 10 ans.Renseignements thérapeutiques fournis aux médecins et aux pharmaciens sur demande.

Store at controlled room temperature (15-30˚C).

Conserver à la température ambiante contrôlée (15 - 30 ˚C).

*TM/M.C. de Erfa Sciences Inc.Erfa Canada Inc., licensee/licenciéWestmount (Québec) H3Z 1E8

9203

530

008

60 100 mg oxtriphylline/5 mL

d'oxtriphylline/5 mL

Erfa Canada Inc., 4545 Sherbrooke OuestWestmount QCH3Z 1E8 Canada

peripheral VasodilatorNylidrin acts predominantly by beta receptor stimulation. It has been shown to dilate arteri-oles in skeletal muscle and to increase cardiac output. ARLIDIN may be of benefit in elderly patients with mild to moderate symptoms that are commonly associated with organic mental disorders. Short-term (3-month duration) and long-term (12-month duration) clinical studies have demonstrated a modest improvement in ability to perform general activities of daily living, self care and in a capability for social interactions.

ARLIDIN has been shown to be of possible ben-efit in peripheral vascular disorders. It increases walking ability and promotes healing of trophic ulcers associated with: arteriosclerosis obliter-ans, thromboangiitis obliterans (Buerger’s dis-ease), diabetic vascular disease, night leg cramp, Raynaud’s phenomenon, ischemic ulcers, frost bite, and thrombophlebitis.

ARLIDIN®

(Nylidrin HCl) 6 mg Tablets

sympathomimeticThe most common uses of epinephrine are to relieve respiratory distress due to bron-chospasm, to provide rapid relief of hypersensitivity reactions to drugs and other aller-gens, and to prolong the action of infiltration anesthetics. Its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes. Epinephrine is used as a hemostatic agent. Epinephrine Injection can be used to prolong the action of local anesthetics. Please refer to the product monograph for other indications.

antiarrhythmic agentPROCAN SR is indicated for the treatment of documented life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia. PROCAN SR is also indicated in the treatment of atrial fibrillation, particularly if the condition is of recent development and the treatments of choice cannot be used or are ineffective.

ADRENALINCHLORIDEINjECTION®

(Epinephrine Injection, USP)1:1000, 30 mg/30 mL (1 mg/mL)

ADRENALINCHLORIDE TOPICALSOLUTION®

(Epinephrine Nasal Solution, USP)1:1000, 30 mg/30 mL (1 mg/mL)

PROCANSR® (Procainamide Hydrochloride Extended-Release, USP)250, 500 and 750 mg Tablets

36

9203

530

036

AntiarythmiquePour le traitement d’entretien seulementDose pour adultes : La dose d’entretien recommandée chez l’adulte est de 50 mg/kg de poids corporel par jour, en prises réparties toutes les 6 heures. La dose quotidienne maximale de Procan* SR ne doit pas dépasser 4 g.Monographie de produit disponible sur demande.Conserver entre 15 et 30 ˚C. Craint l’humidité.

273H728 C32871Antiarrhythmic

For maintenance therapy only

Adult Dose: Recommended mainten-ance dose is 50 mg/kg body weight per day given in divided doses at 6-hour intervals. Maximum daily dose should not exceed 4 g of Procan* SR.

Product Monograph available on request.

Store between 15-30 ˚C. Protect from moisture.

*TM/M.C. de Erfa Sciences Inc.Erfa Canada Inc., licensee/licenciéMontreal (Québec) H4P 2P5

Procan* SRProcainamide HydrochlorideExtended-release Tablets U.S.P.Dissolution Test 2 / Comprimésde chlorhydrate de procaïnamideUSP à libération prolongée. Essain˚ 2 sur la dissolution

250 mg100 tablets / comprimés

DIN 00638692Pr

Erfa Canada Inc., Montreal, QCH4P 2P5

anxiolytic - antihistamine agentATARAX is indicated in the management of anxiety and tension as in the preparation for dental proce-dures and in acute emotional problems. Also used in the management of anxiety associated with organic disturbances and as adjunctive therapy in alcoholism and allergic conditions with strong emotional overlay, such as in asthma.

ATARAX is useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses.

ATARAX is also useful in the control of nausea and vomiting, excluding nausea and vomiting of preg-nancy.

ATARAXSYRUP®

(Hydroxyzine hydrochloride Syrup, USP)2 mg/mL or 10 mg/ 5 mL

ENDOCRINOLOGY / ANALGESICS / ANTIHISTAMINE

progestinNORLUTATE is indicated in the treatment of: - Amenorrhea - Endometriosis - Abnormal uterine bleeding due

to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer.

NORLUTATE®

(Norethindrone Acetate, USP)5 mg Tablets

antipruritic-antihistamineTrimeprazine is a propylamino pheno-thiazine derivative with reduced central activity and enhanced antihistaminic and antipruritic effects.

It is indicated in pruritus regardless of site or etiology. PANECTYL is also indi-cated in the control of cough of various etiologies and the relief of asthma like dyspnea.

PANECTYL® (Trimeprazine Tartrate)2.5 mg, 5 mg Tablets

analgesicPONSTAN® is indicated for the relief of pain of moderate severity in conditions such as: - muscular aches and pains - primary dysmenorrhea - headache - dental pain

Hypothyroidism therapyThyroid is indicated in the treatment of hypothy-roidism. It contains T3, T4 and several other com-ponents naturally present in porcine thyroid gland.

THYROID®

(Desiccated Thyroid)30, 60, 125 mg Tablets

PONSTAN®

(Mefenamic Acid, BP)250 mg Capsules

ANTIBIOTICS / ANTISEPTIC / PROBIOTICS

antibioticChloramphenicol is an antibiotic that exerts mainly a bacteriostatic effect on a wide range of Gram-negative and Gram-positive bacteria and is active against rickettsiae, the lymphogranuloma-psittacosis group and Vibrio cholerae. It is particularly active against Salmonella typhi and Haemophilus influenzae. It is an important part of the cystic fibrosis regimens.

urinary antibacterialMethenamine mandelate, a urinary anti-bacterial agent, is the chemical combina-tion of mandelic acid with methenamine. MANDELAMINE is indicated for the sup-pression or elimination of bacteriuria as-sociated with pyelonephritis, cystitis and other urinary tract infections; also those neurologic diseases leading to an infected residual urine.

BACID®

(Lactobacillus Rhamnosus)1 billion UI

CHLOROMYCETINSUCCINATEINjECTION®

(Chloramphenicol Sodium Succinate for Injection PH. EUR)Equivalent to 1g chloramphenicol per vialFor Intravenous Use

MANDELAMINE®

(Methenamine Mandelate, USP)500 mg TabletsHUMATIN®

(Paromomycin Sulfate, Manufacturer standard)250 mg Capsules

COLY-MYCINMPARENTERAL®

(Colistimethate for Injection, USP) (Sterile Colistimethate sodium)Equivalent to 150 mg colistin base

Flora ModifierBACID is a Flora Modifier that is able to as-sist in the restoration and maintenance of the normal physiological and bacterial flora of the oral and intestinal tracts, following antibiotic-induced stomatitis and diarrhea.

BACID should be stored in a refrigerator at a temperature of 10°C, or below to maintain potency.

C32901

DIN 00476714

Preserve in tight containers.

Garder dans des flaconshermétiquement fermés.

*TM/M.C de Erfa Sciences Inc.Erfa Canada Inc. licensee/licenciéMontreal (Quebec) H4P 2P5

Conserver entre 15 et 30°C.

Store between 15 to 30°C.

Pyridium*Pr

PhenazopyridineHydrochloride TabletsU.S.P./Comprimés dechlorhydrate de phénazopyridine, U.S.P.100 mg50 tablets / comprimés

Erfa Canada Inc.Montreal, QCH4P 2P5

Urinary AnalgesicDosage: 2 tablets three times daily after meals.Not for use in children.Product Monograph availableto health care professional onrequest.

Analgésique pour l’appareilurinairePosologie : 2 comprimés troisfois par jour après les repas. Ne doit pas être utilisé chez les enfants.Les professionnels de la santé peuvent recevoir la monographie deproduit sur demande.

6797

55 /

00

antibioticCOLY-MYCIN M is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. It is particularly indicated when the infection is caused by sensitive strains of P. aeru-ginosa. Sodium colistimethate has proven clinically effective in treatment of infections due to the follow-ing gram-negative organisms: A. aerogenes, E. coli, K. pneumoniae and P. aeruginosa. This antibiotic is not indicated for infections due to proteus or neisseria.

antibioticHUMATIN (Paromomycin Sulfate) is a broad spectrum aminoglyco-side antibiotic. HUMATIN (Paro-momycin Sulfate) is indicated for the treatment of intestinal am-ebiasis, acute and chronic.

urinary tract analgesicPYRIDIUM® is indicated for the symptomatic relief of pain, burning, urgency, frequency, and other discomforts resulting from irritation of the mucosa of the lower urinary tract caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters.

PYRIDIUM® is compatible with antimicrobial therapy and can help relieve pain and dis-comfort during the interval before an antimicrobial therapy controls the infection.

PYRIDIUM®

(Phenazopyridine Hydrochloride, USP)100 and 200 mg Tablets

ANTIBIOTICS / ANTISEPTIC / PROBIOTICS ANTICONVULSANT

AntibioticFramycetin, a broad spectrum aminoglycoside antibiotic, is usually bactericidal in action. Fra-mycetin is active against many aerobic gram-negative bacteria and some aerobic gram-pos-itive bacteria

SOFRAMYCIN Nasal Spray is used in the lo-cal treatment of infections and/or congestion caused by susceptible organisms in acute rhi-no-sinusitis, crusting rhinitis, nasal conditions accompanying the common cold and for post-operative care of patients who have undergone intranasal or sinus surgery. Prophylactic use, for reduction of nasal carriage of staphylococci is also indicated.

SOFRAMYCIN Skin Ointment is used for the lo-cal treatment of infections caused by pyogenic organisms, in particular S. aureus, the proteus

group of bacteria, coliforms and P. aeruginosa. It is also used for the treatment of bacterial infections of the skin and mucous membrane caused by susceptible bacteria. These include such conditions as pyoderma, folliculitis, paro-nychia, sycosis barbae, and impetigo. Also use-ful in controlling secondary bacterial infections in skin carcinoma, burns, eczemas, contact dermatitis, seborrhea, acne, psoriasis, varicose ulcers and neurodermatitis.

SOFRAMYCIN Ophthalmic drops is used for the local treatment of infections caused by pyogenic organisms, in particular S. aureus, the proteus group of bacteria, coliforms and P. aeru-ginosa. It is also used for the treatment of bac-terial blepharitis, conjunctivitis, styes, corneal abrasions and burns as well as prophylaxis fol-lowing removal of foreign bodies in the cornea.

TopicalAntibioticA lightweight, lano-paraffin (anhydrous lanolin 9.95%) gauze dressing impreg-nated with 1% framycetin sulfate BP. Use for the treatment of infected or potentially infected burns, wounds, ulcers and graft sites.

SOFRAMYCIN®

Nasal Spray(Framycetin-Phenylephrine Combination)Antibiotic-Decongestant

SOFRAMYCIN® Skin Ointment(Framycetin-Gramycidin Combination)Antibiotic

SOFRAMYCIN®

Sterile Eye Drops(Framycetin)Antibiotic

SOFRA-TULLE® (Framycetin sulfate, BP 1%) antiepileptic agent

Following parenteral administration of CEREBYX, fosphenytoin is converted to the anticonvulsant phenytoin.

CEREBYX can be used for the control of generalized convulsive status epilepticus and prevention and treatment of seizures occur-ring during neurosurgery. It can also be substituted, short-term, for oral phenytoin.

CEREBYX is indicated for short-term parenteral administration when other means of phenytoin administration are unavailable, inappropriate or deemed less advantageous.

anticonvulsantZARONTIN is used for the control of absence (petit mal) epilepsy. Ethosuximide may be administered in combination with other anticonvulsants when other forms of epilepsy co-exist with absence (petit mal).

CEREBYX®

(Fosphenytoin Sodium Injection, 75 mg/ml)Equivalent to 50 mg/mL Phenytoin Sodium

ZARONTIN®

(Ethosuximide, USP)250 mg Capsules

(Ethosuximide, BP)250 mg/5 mL (50 mg/mL) Solution

ANTIDEPRESSANT

LITHANE®

(Lithium Carbonate) 150 mg and 300 mg Capsules

antimanic agentLITHANE is indicated in the treatment of acute manic episodes in patients with manic-depressive disorders. Maintenan-ce therapy has been found useful in preventing or diminishing the frequency of subsequent relapses in bipolar manic-depressive patients (with a strong history of mania).

psychotropic agentNEULEPTIL is a sedative phenothi-azine with weak antipsychotic proper-ties. It also has adrenolytic, anticholin-ergic metabolic and endocrine effects and an action on the extrapyramidal system. NEULEPTIL is used as ad-junctive medication in some psychot-ic patients, for the control of residual prevailing hostility, impulsiveness and aggressiveness.

antiparkinsonian agentPARSITAN is used in the symptomatic treatment of drug induced extrapyrami-dal manifestations and of Parkinson’s disease of postencephalitic, arterioscle-rotic or idiopathic etiology.

antidepressant and anxiolyticSINEQUAN is a psychotropic agent with antidepres-sant and anxiolytic properties. The antidepressant and anxiolytic properties of SINEQUAN have been found to be of value in the drug treatment of:

• Psychoneurotic patients with anxiety and/or de-pressive reactions;

- Anxiety neurosis associated with somat-ic disorders;

- Alcoholic patients with anxiety and/or depression.

• Psychotic depression, including manic-depressive illness (depressed type) and involutional melan-cholia.

antipsychotic agentThiothixene is an antipsychotic agent useful in the man-agement of schizophrenia and other psychotic disorders. NAVANE is an antipsychotic agent of the thioxanthene se-ries. NAVANE possesses certain chemical and pharma-cologic similarities to the piperazine phenothiazines and differences from the aliphatic group of phenothiazines.

As with other antipsychotic agents, some patients resis-tant to previous medication have responded favorably to NAVANE. It may also be of value in the management of withdrawn, apathetic schizophrenic patients.

NARDIL®

(Phenelzine Sulfate, USP)15 mg Tablets

PARSITAN®

(Ethopropazine HCl)50 mg Tablets

SINEQUAN®

(Doxepin hydrochloride)10 mg, 25 mg, 50 mg, 75 mg Capsules

NEULEPTIL®

(Periciazine)Drops 10 mg/mL 5 mg, 10 mg, 20 mg Capsules

NAVANE® (Thiotixene)2 mg and 5 mg Capsules

antidepressantNARDIL is a potent monoamine oxidase (MAO) inhibi-tor. NARDIL is indicated in the treatment of depressed patients clinically characterized as «atypical», «non-endogenous» or «neurotic». These patients often have mixed anxiety and depression and phobic or hypochondriacal features. There is less conclusive evidence of its usefulness for severely depressed pa-tients with endogenous features. NARDIL is indicated for patients who have failed to respond to the drugs more commonly used for these conditions.

ONCOLOGY CENTRAL NERVOUS SYSTEM

ERFA Canada 2012 Inc. is committed in the years to come to maintain a supply of niche products on the market for the well-being of Canadian patients.

ECI2012isaprouddonortotheseinstitutions:Montreal Children’s Hospital;

CHU Sainte-Justine Foundation;Montreal Heart Institute Foundation;

The Princess Margaret Cancer Foundation;SickKids Foundation;

Toronto General and Western Hospital Foundation.

antimitotic - antibiotiqueDaunorubicin inhibits the synthesis of nucleic acids. It is indicated in the initial treatment of myeloblastic and acute lymphoblastic leukemias. Daunorubicin can also induce a remission in patients suffering from chronic myeloid leukemia, reticulosarcoma, Ewing or Wilms’ tumors and lymphosarcoma.

CERUBIDINE®

(Daunorubicin)20 mg Vial

antineoplastic agentAMSA PD is a potent cytotoxic agent. It is indicated for induction of remission in acute adult leukemia refractory to conventional ther-apy. AMSA PD treatment is not contraindi-cated in patients who have received previous treatment with doxorubicin or daunorubicin. AMSA PD is an important antineoplastic agent in patients refractory to other treatments.

AMSAPD®

(Amsacrine Injection)75 mg/1.5 mL Ampoule (50 mg/mL)

parenteral general anestheticKetalar can be used as the sole anesthetic agent for recommended diagnostic and surgical pro-cedures, for the induction of anesthesia prior to the administration of other general anesthetic agents as well as to supplement low potency agents such as nitrous oxide. It is also used in extra peritoneal procedures used in gynecology such as dilation and curettage, in orthopedic procedures, in dental extractions, in miscella-neous procedures of general surgery, in anes-thesia in poor-risk patients where depression of vital functions precludes the use of other general anesthetics as well as in procedures where the intramuscular route of administration is preferred.

KETALAR®

(Ketamine Hydrochloride Injection, USP)10 mL vial 20 mL vial 500 mg/10 mL 200 mg/20 mL50 mg/mL 10 mg/mL

8250 Decarie - suite 110, Montreal QC Canada H4P 2P5

Phone: +1 514-931-3133Toll Free: 1 888-922-3133

Fax: +1 514-931-7330E-mail: info@eci2012.net

www.eci2012.net